Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis
Nutrients · 2024
DOI: 10.3390/nu16234109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Na-Ra Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Proto-Oncogene Proteins c-akt, NF-kappa B, Oncostatin M. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Background
Oncostatin M (OSM) is involved in several inflammatory responses. Tryptanthrin (TRYP), as a natural alkaloid, is a bioactive compound derived from indigo plants. Objectives/ Methods: The purpose of this study is to investigate the potential inhibitory activity of TRYP on OSM release from neutrophils using neutrophils-like differentiated (d)HL-60 cells and neutrophils from mouse bone marrow.
Results
The results showed that TRYP reduced the production and mRNA expression levels of OSM in the granulocyte–macrophage colony-stimulating factor (GM-CSF)-stimulated neutrophils-like dHL-60 cells. In addition, TRYP decreased the OSM production levels in the GM-CSF-stimulated neutrophils from mouse bone marrow. TRYP inhibited the phosphorylation of phosphatidylinositol 3-kinase (PI3K), AKT, and nuclear factor (NF)-κB in the GM-CSF-stimulated neutrophils-like dHL-60 cells.
Conclusions
Therefore, these results reveal for the first time that TRYP inhibits OSM release via the down-regulation of PI3K-AKT-NF-κB axis from neutrophils, presenting its potential as a therapeutic agent for inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Anatomy & Information Sciences, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Center for Converging Humanities, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Seong-Gyu Ko
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
- National Research Foundation of Korea (NRF)
Zitieren
APA
Han, N. R., Park, H. J., Ko, S. G., & Moon, P. D. (2024). Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis. Nutrients. https://doi.org/10.3390/nu16234109
Vancouver
Han NR, Park HJ, Ko SG, Moon PD. Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis. Nutrients. 2024. doi:10.3390/nu16234109
BibTeX
@article{Han2024,
author = {Han, Na-Ra and Park, Hi-Joon and Ko, Seong-Gyu and Moon, Phil-Dong},
title = {Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16234109}
}
EUVIMED